Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Infect Dis ; 144: 107053, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38641317

RESUMO

BACKGROUND: Vietnam continues to have measles and rubella outbreaks following supplementary immunization activities (SIA) and routine immunization despite both having high reported coverage. To evaluate immunization activities, age-specific immunity against measles and rubella, and the number of averted Congenital Rubella Syndrome (CRS) cases, must be estimated. METHODS: Dried blood spots were collected from 2091 randomly selected individuals aged 1-39 years. Measles and rubella virus-specific immunoglobulin G (IgG) were measured by enzyme immunoassay. Results were considered positive at ≥120 mIU/mL for measles and ≥10 IU/mL for rubella. The number of CRS cases averted by immunization since 2014 were estimated using mathematical modelling. RESULTS: Overall IgG seroprevalence was 99.7% (95%CI: 99.2-99.9) for measles and 83.6% (95%CI: 79.3-87.1) for rubella. Rubella IgG seroprevalence was higher among age groups targeted in the SIA than in non-targeted young adults (95.4% [95%CI: 92.9-97.0] vs 72.4% [95%CI: 63.1-80.1]; P < 0.001). The estimated number of CRS cases averted in 2019 by immunization activities since 2014 ranged from 126 (95%CI: 0-460) to 883 (95%CI: 0-2271) depending on the assumed postvaccination reduction in the force of infection. CONCLUSIONS: The results suggest the SIA was effective, while young adults born before 1998 who remain unprotected for rubella require further vaccination.


Assuntos
Anticorpos Antivirais , Imunoglobulina G , Sarampo , Rubéola (Sarampo Alemão) , Humanos , Imunoglobulina G/sangue , Sarampo/epidemiologia , Sarampo/prevenção & controle , Sarampo/imunologia , Adolescente , Pré-Escolar , Criança , Rubéola (Sarampo Alemão)/epidemiologia , Rubéola (Sarampo Alemão)/imunologia , Rubéola (Sarampo Alemão)/prevenção & controle , Adulto , Masculino , Estudos Soroepidemiológicos , Feminino , Adulto Jovem , Lactente , Anticorpos Antivirais/sangue , Modelos Teóricos , Vacina contra Rubéola/imunologia , Vacina contra Rubéola/administração & dosagem , Vírus da Rubéola/imunologia , Prevalência , Vacina contra Sarampo/imunologia , Vacina contra Sarampo/administração & dosagem , Fatores Etários , Vacinação , Programas de Imunização , Síndrome da Rubéola Congênita/epidemiologia , Síndrome da Rubéola Congênita/prevenção & controle , Síndrome da Rubéola Congênita/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...